Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Operating Margin (2025 - 2026)

Global Innovative Platforms' (GIPL) quarterly Operating Margin came in at 476.55% in Q2 2026, down 235.25% quarter-over-quarter from 142.15% in Q1 2026.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Global Innovative Platforms (GIPL) Operating Margin (2025 - 2026) Analysis & Trends

Global Innovative Platforms has disclosed Operating Margin across 2 years of filings, most recently posting 476.55% for Q2 2026.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn 34.98%
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn 33.91%
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn 18.13%
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn 12.14%
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn 26.93%
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -476.55%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -476.55%
Mar 31, 2026 -142.15%
Dec 31, 2025 -164.76%